Showing results (251-260 of 9,917) with videos related to

Sort By:
Pageof 992
Bone Marrow Transplantation|June 6, 2007
Prophylactic fresh frozen plasma may prevent development of hepatic VOD after stem cell transplantation via ADAMTS13-mediated restoration of von Willebrand factor plasma levelsM Matsumoto, K Kawa, M Uemura, et al.
Bone Marrow Transplantation|January 31, 2007
Patients at high risk for CMV infection and disease show delayed CD8+ T-cell immune recovery after allogeneic stem cell transplantationS Ganepola, C Gentilini, U Hilbers, et al.
Bone Marrow Transplantation|January 31, 2007
Autologous stem cell transplantation is safe and feasible in elderly patients with multiple myelomaM H Qazilbash, R M Saliba, C Hosing, et al.
Bone Marrow Transplantation|January 25, 2007
Current status of JACIE accreditation in Europe: a special report from the Joint Accreditation Committee of the ISCT and the EBMT (JACIE)D Samson, I Slaper-Cortenbach, D Pamphilon, et al.
Bone Marrow Transplantation|January 25, 2007
High-dose caspofungin combination antifungal therapy in patients with hematologic malignancies and hematopoietic stem cell transplantationA Safdar, G Rodriguez, K V I Rolston, et al.
Bone Marrow Transplantation|October 1, 1991
A simplified method for cryopreservation of peripheral blood stem cells at -80 degrees C without rate-controlled freezingS Makino, M Harada, K Akashi, et al.
Bone Marrow Transplantation|January 16, 2007
Fludarabine vs cladribine plus busulfan and low-dose TBI as reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation: a prospective randomized trialM Markova, J N Barker, J S Miller, et al.
Bone Marrow Transplantation|April 3, 2007
Targeting the stem cell niche: squeezing blood from bonesK Ballen
Bone Marrow Transplantation|April 10, 2007
Early recovery of aggressive cytotoxic cells and improved immune resurgence with post-transplant immunotherapy for multiple myelomaK R Meehan, J Wu, E Bengtson, et al.
Bone Marrow Transplantation|May 16, 2007
Prophylactic defibrotide in allogeneic stem cell transplantation: minimal morbidity and zero mortality from veno-occlusive diseaseF Dignan, D Gujral, M Ethell, et al.
Pageof 992